ArticleVaccines2023

Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Israel Henig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.